8-KThe WireRoutine
Shareholder Vote
Filed May 12, 2017 · 9y ago · Accession 0001437749-17-008962
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
_______________________
Date of Report
(Date of earliest
event reported):
May 9, 2017
National Research Corporation
(Exact name of registrant as specified in its charter)
Wisconsin
0-29466
47-0634000
(State or other
jurisdiction of
incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
1245 Q Street, Lincoln, Nebraska 68508
(Address of principal executive offices, including zip code)
(402) 475-2525
(Registrant ’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company □
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □
Item 5.07 .
Submission of Matters to a Vote of Security Holders .
On May 9, 2017, National Research Corporation (the “Company”) held its 2017 annual meeting of shareholders (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders voted on the following proposals:
●
The election of two directors, JoAnn M. Martin and Barbara J. Mowry, to the Company’s Board of Directors for three-year terms to expire at the Company’s 2020 annual meeting of shareholders;
●
The ratification of the appointment of KPMG LLP as the Company ’s independent registered public accounting firm for 2017;
●
An advisory vote to approve the compensation of the Company ’s named executive officers as disclosed in the proxy statement; and
●
An advisory vote on the frequency of the advisory shareholder vote on the compensation of the Company’s named executive officers.
As of the March 1 4, 2017 record date for the determination of the shareholders entitled to notice of, and to vote at, the Annual Meeting, 20,913,343 shares of the Company’s class A common stock were outstanding and eligible to vote with an aggregate of 209,133.43 votes; and 3,543,463 shares of the Company’s class B common stock were outstanding and eligible to vote with an aggregate of 3,543,463 votes. Approximately 87.22% of all votes were represented at the Annual Meeting in person or by proxy. The following are the final votes on the matters presented for shareholder consideration at the Annual Meeting:
Election of Directors
The shareholders elected JoAnn M. Martin and Barbara J. Mowry as directors for three-year terms to expire at the Company’s 2020 annual meeting of shareholders. The results of the vote were as follows:
For
Withheld
Broker Non-Votes
Name
Votes
Percentage (1)
Votes
Percentage
Votes
Percentage (2)
JoAnn M. Martin
3,227,037.46
98.60 %
45,873.95
1.40 %
0.00
N/A
Barbara J. Mowry
3,227,103.65
98.60 %
45,807.76
1.40 %
0.00
N/A
Ratify Appointment of KPMG LLP for 2017
The shareholders ratified the appointment of KPMG LLP as the Company ’s independent registered public accounting firm for 2017. The results of the vote were as follows:
For
Against
Abstain
Broker Non-Votes
Votes
Percentage (1)
V otes
Percentage (1)
Votes
Percentage (2)
Votes
Percentage (2)
3,195,998.47
99.99 %
269.66
0.01 %
76,643.28
N/A
0.00
N/A
-2-
Advisory Vote to Approve Executive Compensation
The shareholders approved the compensation of the Company ’s named executive officers as disclosed in the proxy statement. The results of the advisory vote were as follows:
For
Against
Abstain
Broker Non-Votes
Votes
Percentage (1)
Votes
Percentage (1)
Votes
Percentage (2)
Votes
Percentage (2)
3,260,315.77
99.93 %
2,236.65
0.07 %
10,357.99
N/A
0.00
N/A
Advisory Vote on the Frequency of the Advisory Shareholder Vote on Executive Compensation
The shareh olders expressed a preference that an advisory vote on the compensation of the Company’s named executive officers occur every year. The results of the advisory vote were as follows:
Every Year
Every Two Years
Every Three Years
Abstain
Votes
Percentage (1)
Votes
Percentage (1)
Votes
Percentage (1)
Votes
Percentage (1)
3,159,196.27
96.79 %
5,499.61
0.17 %
99,295.53
3.04 %
8,920.00
N/A
Broker Non-Votes
Votes
Percentage (2)
0.00
N/A
In accordance with the results of this vote, the Board of Directors of the Company determined to implement an advisory shareholder vote to approve the compensation of the Company’s named executive officers every year until the next required advisory vote on the frequency of the advisory shareholder vote on the compensation of the Company’s named executive officers, which is scheduled to occur at the Company’s 2023 annual meeting of shareholders.
_______________
(1) Based on a total of all votes received and eligible to be counted as voted on this proposal at the Annual Meeting.
(2) “N/A” means that abstentions and/or broker non-votes do not have any effect on the voting results on this proposal.
-3-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 12, 2017
NATIONAL RESEARCH CORPORATION
By :
/s/ Kevin R. Karas
Kevin R. Karas
Senior Vice President Finance, Chief Financial
Officer, Treasurer and Secretary
-4-
Filing details
- Company
- NRC HEALTH
- Ticker
- NRC
- CIK
- 70487
- Form type
- 8-K
- Filing date
- May 12, 2017
- Report date
- May 9, 2017
- Document
- nrci20170511_8k.htm
- Size
- 55 KB